Quantcast

Latest Charles A. Dinarello Stories

2011-02-24 07:00:00

DENVER, Feb. 24, 2011 /PRNewswire/ -- (OTC Bulletin Board: OMBP): Omni Bio Pharmaceutical, Inc. ("Omni Bio") today announced that effective March 1, 2011, Dr. James Crapo will become its Chief Executive Officer. The board of directors of the Company anticipates appointing Dr. Crapo as a director in the near term. Dr. Charles Dinarello, who has served as Omni Bio's acting Chief Executive Officer since its inception in March 2009, will become Omni's Chief Scientific Officer and Chief...

2011-01-04 07:00:00

DENVER, Jan. 4, 2011 /PRNewswire/ -- Omni Bio Pharmaceutical, Inc. ("Omni Bio") (OTC Bulletin Board: OMBP), today announced that U.S. Patent No. 7,850,970, entitled "Inhibitors of Serine Protease Activity and Their Use in Methods and Compositions for Treatment of Bacterial Infections," was issued by the United States Patent and Trademark Office (USPTO) on December 14, 2010 (the "New Patent"). The New Patent is part of the technology licensed to Omni Bio through one of its technology...

2010-10-20 18:36:44

A husband and wife research team from Melbourne, Australia, have identified a protein that may be a key therapy for many inflammatory diseases, including those affecting premature babies. In the October edition of Nature Immunology, Drs Marcel and Claudia Nold, from the Monash Institute of Medical Research, describe how a protein, interleukin 37 (IL"37), reacts when an inflammatory response is detected in the body. "Our bodies mount an inflammatory response to protect against an...

2009-06-10 07:00:00

MINNEAPOLIS, June 10 /PRNewswire-FirstCall/ -- Charles A. Dinarello, M.D., a Professor of Medicine at the University of Colorado School of Medicine in Denver and a member of the Techne Corporation Board of Directors, was recently recognized with two distinguished awards. On April 26, 2009, Dr. Dinarello, Ralph M. Steinman, M.D., of Rockefeller University and Bruce Beutler, M.D., of The Scripps Research Institute, were the 2009 recipients of the Albany Medical Center Prize in Medicine and...

2008-09-22 09:00:58

BERKELEY, Calif., Sept. 22, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that the company will host a live web cast of its analyst and investor event on September 25, 2008 at 5:00 PM Eastern. The event, titled "Interleukin-1 Blockers: Unlocking Their Potential in Diabetes and Beyond," will feature guest speakers Charles A. Dinarello, M.D. and Marc Y. Donath, M.D., who will discuss Interleukin-1 (IL-1)...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related